feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / RA Treatment Delays Disease for Years

RA Treatment Delays Disease for Years

21 Jan

•

Summary

  • Treatment with abatacept delays rheumatoid arthritis onset.
  • Benefits of abatacept treatment extended for years.
  • Study shows delayed disease onset up to four years.
RA Treatment Delays Disease for Years

Researchers have discovered that a specific treatment can effectively delay the onset of rheumatoid arthritis (RA) in individuals identified as high risk for the disease.

The study, led by King's College London, assessed the longer-term impact of abatacept, a drug designed to target the root causes of inflammation associated with RA.

Findings indicate that the positive effects of abatacept persisted well past the initial one-year treatment course. Participants receiving the drug experienced a significantly longer period before developing RA compared to those given a placebo, with disease onset delayed by up to four years after treatment concluded.

trending

Aurora borealis UK forecast tonight

trending

RRB NTPC application status released

trending

Intel earnings report in focus

trending

Arsenal beat Inter 3-1

trending

Olympiacos vs Leverkusen Champions League

trending

Mbappe defends Real Madrid teammates

trending

Napoli losing streak continues

trending

Premier League Champions League games

trending

Gabriel Jesus wants Arsenal stay

While not a permanent cure, the research suggests abatacept can postpone the disease's development. Professor Andrew Cope highlighted that early intervention offers lasting benefits, is safe, and can substantially improve patients' quality of life by reducing the duration of symptoms and complications.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Abatacept can significantly delay the onset of rheumatoid arthritis for up to four years, even after treatment stops, but it does not permanently prevent the disease.
Delaying RA onset can reduce the time patients live with symptoms and complications, drastically improving their quality of life and independence.
Rheumatoid arthritis affects individuals where the immune system attacks healthy tissues, leading to joint inflammation, pain, swelling, and stiffness.

Read more news on

Healthside-arrow

You may also like

Stanford Scientists Discover Arthritis Cartilage Repair

9 Jan • 76 reads

article image

New Orthopedic Specialist Joins Ashland Hospital

11 Jan • 57 reads

Miracle Drug Helps Boy Walk After Rare Genetic Disorder

1 Jan • 111 reads

article image

Singer's Near-Fatal Battle with Flesh-Eating Disease

23 Dec, 2025 • 96 reads

Parents Fear Asthma Dismissal After Daughter's Death

18 Dec, 2025 • 122 reads

article image